Evommune, Inc. (EVMN)

NYQ – Real vaqt narxi. Valyuta: USD

14.03

-0.18 (-1.27%)

Bozor ochiq: Aug 12, 2026, 3:23 PM EDT

14.21

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc. (NYSE: EVMN) (“Evommune” or the “Company”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a business update. "There are still no first-line oral options for patients suffering with AD that combine lesion control, itch relief and tolerability. That gap is where we.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Evommune, Inc. (EVMN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Evommune, Inc. (EVMN)

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videolar

No Data

Press-relizlar

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videolar

No Data

Press-relizlar

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Search stocks

Evommune, Inc. (EVMN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Evommune, Inc. (EVMN)

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videolar

No Data

Press-relizlar

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videolar

No Data

Press-relizlar

Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights